AnalystsSteven Lichtman
Steven Lichtman's Stock Forecasts

Analyst Ranking
Top 33%
#1594 out of 4872 analysts
Average Return
+1.32%
Win Rate
40%19 out of 47
Risk vs Reward
Poor
Good

Steven Lichtman's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Brainsway LtdBWAY
+234.16%$1.61$5.38
2023-05-17 -
2024-05-17
Buy
Rxsight IncRXST
+208.23%$17.87$55.08
2023-04-12 -
2024-04-12
Buy
Brainsway LtdBWAY
+95.29%$4.67$9.12
2023-11-15 -
2024-11-15
Buy
Modular Medical IncMODD
+93.97%$1.16$2.25
2023-09-18 -
2024-09-18
Buy
Modular Medical IncMODD
+71.84%$1.03$1.77
2023-05-18 -
2024-05-17
Buy

Steven Lichtman Analyst Color

Get additional color on Steven Lichtman's coverage of popular stocks

Steven Lichtman's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Dexcom IncDXCM
8Buy$105.00+30.81%Maintains
6 months ago
Zimmer Biomet Holdings IncZBH
6Buy$135.00+49.20%Maintains
7 months ago
Mannkind CorpMNKD
1Buy$12.00+141.94%Maintains
8 months ago
Alcon IncALC
3Buy$110.00+12.96%Maintains
8 months ago
Medtronic PLCMDT
7Hold$94.00+12.64%Maintains
9 months ago
Rxsight IncRXST
8Buy$65.00+343.99%Maintains
9 months ago
Tandem Diabetes Care IncTNDM
1Buy$58.00+172.43%Maintains
a year ago
Brainsway LtdBWAY
4Buy$11.00+26.29%Maintains
a year ago
Angiodynamics IncANGO
2Buy$12.00N/AUpgrades
a year ago
Merit Medical Systems IncMMSI
1Buy$87.00N/AMaintains
a year ago
Boston Scientific CorpBSX
2Hold$68.00N/AMaintains
a year ago
Modular Medical IncMODD
2Buy$3.50N/AReiterates
2 years ago
Conformis IncCFMS
8Buy$8.00N/AMaintains
2 years ago
Insulet CorpPODD
2Buy$275.00N/AUpgrades
3 years ago
Stryker CorpSYK
1Hold$288.00N/AMaintains
4 years ago
Glaukos CorpGKOS
3Hold$105.00N/ADowngrades
4 years ago
Staar Surgical CoSTAA
1Hold$150.00N/AInitiates Coverage On
4 years ago
Cooper Companies IncCOO
3Hold$85.00N/AMaintains
5 years ago
Valeritas Holdings IncVLRXQ
1HoldN/AN/ADowngrades
5 years ago
Avinger IncAVGR
1Buy$1,800,000.00N/AInitiates Coverage On
10 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.